Overview

Targin for Non-cancer Pain

Status:
Completed

Trial end date:
2017-03-30

Target enrollment:

Participant gender:

Summary

To determine the improvement in symptoms of constipation in subjects receiving treatment with oxycodone/naloxone prolonged release tablets (OXN) compared to oxycodone prolonged release tablets (OXY) based on the Bowel Function Index (BFI)

Phase:

Phase 3

Details

Lead Sponsor:

Mundipharma (China) Pharmaceutical Co. Ltd

Treatments:

Naloxone
Oxycodone